| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | 0.071 | 0.04 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | -0.34 | 0.04 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.076 | 0.04 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.04 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.072 | 0.04 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | -0.29 | 0.04 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.058 | 0.04 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.068 | 0.05 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | -0.071 | 0.05 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.05 |